Showing results (1601-1610 of 4,056) with videos related to

Sort By:
Pageof 406
Translational Cancer Research|November 14, 2025
A novel prognostic tool for triple-negative breast cancer: creating and testing a parthanatos-related gene modelZitong Yang, Siyi Chen, Jiahong Sun, et al.
Translational Cancer Research|November 14, 2025
PLCXD2 expression relates to the immune microenvironment and prognosis of head and neck squamous cell carcinoma: a retrospective cohort studyMingming Tang, Qingwen Chen, Xinjiang Xu, et al.
Translational Cancer Research|November 14, 2025
A narrative literature review on the clinical utility of activated partial thromboplastin time and anti-factor Xa activity assays in cancer patients with anticoagulant therapyHai-Xin Li, Li-Hong Song, Yan-Hong Chen, et al.
Translational Cancer Research|November 14, 2025
Role of 18F-FDG PET/CT in the diagnosis and treatment response assessment of primary pulmonary lymphomaYongzhu Pu, Ran Xie, Kun Li, et al.
Translational Cancer Research|November 14, 2025
Identification and validation of an immune-related programmed cell death signature for predicting prognosis and immunotherapy in large-scale multicenter cohorts for lung adenocarcinomaZhetao Li, Chuyun Fu, Jie Chen, et al.
Translational Cancer Research|November 14, 2025
Liriopesides B inhibits proliferation and metastasis and induces apoptosis of oral squamous cell carcinoma via the PI3K/Akt/mTOR signaling pathwayJinzhi Wei, Hejia Guo, Binghua Feng, et al.
Translational Cancer Research|November 14, 2025
Epidemiological and clinicopathologic characteristics, and prognostic factors of patients with extra-skeletal osteosarcoma: a Surveillance, Epidemiology, and End Results population studyZhenzhong Liu, Fapeng Gao, Li Du, et al.
Translational Cancer Research|November 14, 2025
Prognostic prediction nomogram of elderly patients with metastasis colon cancer and distant metastasis pattern: a SEER database analysisXing Luo, Jincheng Tang, Wei Peng, et al.
Translational Cancer Research|November 14, 2025
Integrative analysis of polo-like kinase family identifies a prognostic signature and validates PLK2 as a therapeutic target in gliomaChengjun Zheng, Qiaodong Chen, Zheng Fang, et al.
Translational Cancer Research|November 14, 2025
Efficacy, safety and cost-effectiveness of chemo-immunotherapy combinations for recurrent or metastatic nasopharyngeal carcinoma: an updated systematic review and cost-effectiveness analysisLei Qiu, Qiran Wei, Yachun Hu, et al.
Pageof 406